window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 7, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

real-world data

  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    QuantHealth clinical trial simulations deliver $31.4m savings and 90% accuracy

    QuantHealth has simulated more than 350 clinical trials using its [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Opinion & Events

    Sorcero acquires Axiom Health to unify AI insights across pharma and medtech

    Sorcero MedTech launch enables single AI platform for drug and [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Opinion & Events

    Most people with HIV choose long-acting injectables over daily pills

    Cabotegravir and rilpivirine long-acting treatment proves highly effective and widely [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events

    Phesi CEO warns of looming Phase 3 trial failures as sponsors overlook real-world data and overcrowd sites

    New analysis reveals billions risked on overly complex trials that [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Therapeutic Areas

    Caris CMO on AI, equity, and the future of multi-omic oncology

    The former ASCO president shares his insights on breast cancer [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Why generic AI fails pharma and how purpose-built AI is revolutionizing drug development

    Artificial intelligence (AI) is transforming many industries, but in pharma, [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events

    Could a psychedelic transform depression care? Cybin CEO on scaling CYB003 with Osmind deal

    Cybin’s lead psychedelic-based candidate CYB003, designed as an adjunctive treatment [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Cybin teams up with Osmind to advance Phase 3 psychedelic therapy for depression

    As psychedelic-assisted therapies move closer to mainstream psychiatric care, Cybin, [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    myTomorrows unveils new SaaS platform to streamline global expanded access programs

    Health tech company myTomorrows has launched a dedicated platform to [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    myTomorrows tops 15,000 global patient matches for pre-approval treatment access

    Clinical trial platform’s AI and navigator-led model bridges gap in [...]

    May 5, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • How AI is reshaping clinical trials: Saama on the next phase of regulated AI
    Categories: Clinical & Regulatory, Digital & Data, Drug Discovery & Development, Research & Development
  • MRI study suggests some prostate cancer biopsies could eventually be avoided
    Categories: Clinical & Regulatory, Medical devices, Research & Development, Therapeutic Areas
  • START and Allegheny Health Network to expand access to early-phase cancer trials
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top